Mitodys Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Mitodys Therapeutics General Information
Description
Developer of a drug-discovery platform intended to discover and develop therapeutic agents targeted to both the motor and non-motor symptoms prevalent in patients. The company's platform uses the tools of network pharmacology to analyze the interplay between dysfunctional cascading and cooperative cellular and inflammatory functions, enabling physicians to uncover multi-interventional pharmacological agents aimed at alleviating symptoms while modifying the course of the disease.
Contact Information
Website
www.mitodys.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Primary Office
- Cobwebs, Hixet Wood
- Chipping Norton OX7 3SB
- England, United Kingdom
Mitodys Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Mar-2023 | 00000 | Completed | Generating Revenue | ||
| 2. Angel (individual) | 01-Feb-2014 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
| 1. Angel (individual) | 29-May-2013 | $153K | $153K | 00.000 | Completed | Startup |
Mitodys Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 0000 | 0000 | 00 | 0000 | 00.000 | |
| Ordinary | 000 | 00.000000 | 0000.0 | 0000.0 | 00 | 0000.0 | 0.000 | |
| Ordinary | 1,294 | $0.016460 | $127.18 | $127.18 | 1x | $127.18 | 9.76% |
Mitodys Therapeutics Executive Team (3)
Mitodys Therapeutics Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrew Wood | Mitodys Therapeutics | Chief Financial Officer & Board Member | 000 0000 |
| Simon Bennett Ph.D | Mitodys Therapeutics | Chief Business Officer & Board Member | 000 0000 |
| Steven Zimmer | Mitodys Therapeutics | Founder, Chief Executive Officer & Board Member | 000 0000 |